文献速递瘢痕与激光创面修复

乳糜脂肪来源干细胞条件培养基抑制增生性瘢痕成纤维细胞活性

Chyle Fat-Derived Stem Cells Conditioned Medium Inhibits Hypertrophic Scar Fibroblast Activity.
PubMed 文献 · Ann Plast Surg · 2019-01-01

本研究从患者个体分离增生性瘢痕来源成纤维细胞(HSFs)与乳糜脂肪来源干细胞(CFSCs),用机械乳化法分离培养第三代人CFSCs,流式细胞术分析表面CD标志物,油红O与茜素红S染色验证成脂成骨分化能力,并以饥饿诱导的CFSC条件培养基(CFSC-CM)处理HSFs,通过细胞计数、划痕实验、ELISA和Western blot评估细胞增殖、迁移及瘢痕相关蛋白表达。结果显示CFSC-CM抑制HSF增殖与迁移,并降低I型胶原、III型胶原和α平滑肌肌动蛋白表达,提示CFSCs可能通过旁分泌效应抑制HSF纤维化,CFSC-CM或为增生性瘢痕的新型治疗策略。

要点

  • CFSC-CM可抑制增生性瘢痕成纤维细胞的增殖与迁移。
  • CFSC-CM降低HSF中I型胶原、III型胶原及α-SMA表达。
  • CFSCs可能通过旁分泌效应抑制增生性瘢痕纤维化。

核心结论

  • CFSCs可能通过旁分泌效应抑制增生性瘢痕成纤维细胞的纤维化,CFSC-CM或为增生性瘢痕的新型治疗策略。

研究设计与样本

  • 从患者个体分离增生性瘢痕来源成纤维细胞(HSFs)与乳糜脂肪来源干细胞(CFSCs)。
  • 采用机械乳化法分离培养第三代人CFSCs,流式细胞术分析表面CD标志物。
  • 油红O染色与茜素红S染色分别检测CFSCs成脂与成骨分化能力。
  • 以饥饿诱导的CFSC条件培养基(CFSC-CM)处理HSFs,体外评估细胞增殖、迁移及瘢痕相关蛋白表达。

主要发现

  • CFSCs表达CD90、CD105和CD73,不表达CD34、CD45和CD31。
  • CFSCs在适当诱导条件下可分化为脂肪细胞和成骨细胞。
  • CFSC-CM抑制HSF增殖与迁移。
  • 体外与离体研究显示CFSC-CM降低I型胶原、III型胶原和α平滑肌肌动蛋白(α-SMA)表达。

临床怎么用

  • CFSC-CM可作为增生性瘢痕潜在的无细胞治疗策略,通过旁分泌作用抑制成纤维细胞纤维化活性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertrophic scars (HSs) generally form after injury to the deep layers of the dermis and are characterized by excessive collagen deposition. An increasing amount of evidence has determined that human adipose tissue-derived mesenchymal stem cells attenuate fibrosis in various conditions. We explored the effect and possible mechanism of chyle fat-derived stem cells (CFSCs) on HS formation. METHODS: Hypertrophic scar-derived fibroblasts (HSFs) and CFSCs were isolated from individual patients. Third-passage CFSCs were isolated and cultured using a mechanical emulsification method, and their surface CD markers were analyzed by flow cytometry. The adipogenic and osteogenic differentiation capacity of the CFSCs was determined using oil red O staining and alizarin red S staining, respectively. Then, the effects of CFSCs on HSFs were assessed in vitro. Hypertrophic scar-derived fibroblasts were treated with starvation-induced conditioned medium from the CFSCs (CFSC-CM). The change in HSF cellular behaviors, such as cell proliferation, migration, and protein expression of scar-related molecules, was evaluated by cell counting assay, scratch wound assay, enzyme-linked immunosorbent assay, and western blotting. All data were analyzed using SPSS 17.0. RESULTS: The CFSCs expressed CD90, CD105, and CD73 but did not express CD34, CD45, or CD31. The CFSCs differentiated into adipocytes and osteoblasts under the appropriate induction conditions. Chyle fat-derived stem cells conditioned medium inhibited HSF proliferation and migration. The in vitro and ex vivo studies revealed that CFSC-CM decreased type I collagen, type III collagen, and α smooth muscle actin expression. CONCLUSIONS: Our results suggest that CFSCs are associated with the inhibition of fibrosis in HSFs by a paracrine effect. The use of CFSC-CM may be a novel therapeutic strategy for HSs.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Chen J, Li Z, Huang Z, et al. Chyle Fat-Derived Stem Cells Conditioned Medium Inhibits Hypertrophic Scar Fibroblast Activity. Ann Plast Surg. 2019. PMID: 31149905. doi:10.1097/SAP.0000000000001932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。